These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1184013)

  • 1. Association between the C3F gene and atherosclerotic vascular diseases.
    Sorensen H; Dissing J
    Hum Hered; 1975; 25(4):279-83. PubMed ID: 1184013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the C3F-gene and essential hypertension.
    Schaadt O; Sørensen H; Krogsgaard AR
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():363s-365s. PubMed ID: 7318338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3 polymorphism in relation to age.
    Sorensen H; Dissing J
    Hum Hered; 1975; 25(4):284-95. PubMed ID: 1184014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between coronary heart disease and the C3F-gene in essential hypertension.
    Kristensen BO; Petersen GB
    Circulation; 1978 Oct; 58(4):622-5. PubMed ID: 688571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement C3F gene as a risk factor for vascular events in hypertension.
    Sørensen H
    Acta Med Scand Suppl; 1983; 686():49-58. PubMed ID: 6591748
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular analysis of C3 allotypes in patients with systemic vasculitis.
    Finn JE; Zhang L; Agrawal S; Jayne DR; Oliveira DB; Mathieson PW
    Nephrol Dial Transplant; 1994; 9(11):1564-7. PubMed ID: 7870343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 polymorphism in beta-thalassemia.
    Germenis A; Kalantzi M; Karamerou A; Politi C; Fertakis A
    Acta Haematol; 1984; 71(1):45-8. PubMed ID: 6419525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD.
    Ibrahim ST; Chinnadurai R; Ali I; Payne D; Rice GI; Newman WG; Algohary E; Adam AG; Kalra PA
    PLoS One; 2020; 15(1):e0228101. PubMed ID: 32004338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C3 and its polymorphism: biological and clinical consequences.
    Delanghe JR; Speeckaert R; Speeckaert MM
    Pathology; 2014 Jan; 46(1):1-10. PubMed ID: 24300728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3 polymorphism in a Danish cystic fibrosis population and its possible association with antibody response.
    Schiøtz PO; Høiby N; Morling N; Sørensen H
    Hum Hered; 1978; 28(4):293-300. PubMed ID: 658974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between C3 complement types and bronchial asthma.
    Srivastava N; Gupta SP; Srivastava LM
    Hum Hered; 1985; 35(4):263-4. PubMed ID: 4029967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3 polymorphism and circulating immune complexes in patients with multiple sclerosis.
    Jans H; Sørensen H
    Acta Neurol Scand; 1980 Oct; 62(4):237-43. PubMed ID: 7211174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gc and C3 polymorphisms in Central Sardinia.
    Gruppioni G; Lunesu M; Succa V; Vona G
    Hum Hered; 1988; 38(3):178-9. PubMed ID: 3397070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3.
    Poznansky MC; Clissold PM; Lachmann PJ
    J Immunol; 1989 Aug; 143(4):1254-8. PubMed ID: 2473125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement 3 in hypertension and arteriosclerosis].
    Kurochkin GS; Arabidze GG; Liakishev AA; Oshchepkova EV; Gracheva LA; Osipov SG; Titov VN
    Kardiologiia; 1991 Dec; 31(12):28-30. PubMed ID: 1816437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3 polymorphism in Greece.
    Germenis A; Kolitsopoulos A; Dimopoulos AM; Fertakis A
    Hum Hered; 1985; 35(2):123-5. PubMed ID: 3988299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of C3 in the Veneto population, Italy.
    Crestani C; Caenazzo L; Cortivo P; Scorretti C; Caenazzo C
    Anthropol Anz; 1989 Dec; 47(4):299-303. PubMed ID: 2629619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3 polymorphism in North India.
    Sehajpal PK; Tewari K; Singla AK; Kohli AK
    Acta Anthropogenet; 1984; 8(3-4):237-43. PubMed ID: 6545756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of C3 allotypes related to transplant outcome in human renal allografts.
    Andrews PA; Finn JE; Mathieson PW; Sacks SH
    Transplantation; 1995 Dec; 60(11):1342-6. PubMed ID: 8525532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel polymorphism of human complement component C3 detected by means of a monoclonal antibody.
    Koch C; Behrendt N
    Immunogenetics; 1986; 23(5):322-5. PubMed ID: 3519446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.